Guggenheim initiated coverage of DBV Technologies (DBVT) with a Buy rating and $35 price target
TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on DBVT:
- Optimistic Buy Rating for DBV Technologies Amid Promising VIASKIN Peanut Trial Developments
- DBV Technologies announces last patient visit completed in VITESSE trial
- DBV Technologies appoints Kevin Trapp as chief commercial officer
- DBV Technologies Appoints Dr. Philina Lee to Board
- DBV Technologies price target raised to $20 from $16 at H.C. Wainwright